APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oxycodone Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oxycodone Drug Market Analysis and Forecast 2026-2032

30 December 2025217 pages

Choose your research edition.

Industry ResearchOxycodone Drug Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxycodone Drug Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Oxycodone Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxycodone Drug Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxycodone Drug Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Oxycodone Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oxycodone Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oxycodone Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oxycodone Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oxycodone Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Oxycodone Drug include Endone, Endone, Hikma Pharmaceuticals USA, Hikma Pharmaceuticals USA, Janssen Pharmaceuticals(Johnson & Johnson), OxyContin, OxyContin, Oxynorm and Oxynorm, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oxycodone Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oxycodone Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Oxycodone Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oxycodone Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oxycodone Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oxycodone Drug sales, projected growth trends, production technology, application and end-user industry.

Oxycodone Drug Segment by Company

Endone

Endone

Hikma Pharmaceuticals USA

Hikma Pharmaceuticals USA

Janssen Pharmaceuticals(Johnson & Johnson)

OxyContin

OxyContin

Oxynorm

Oxynorm

Proladone

Proladone

Purdue Pharma L.P

Purdue Pharma L.P

Sanofi-Aventis S.A.

Sanofi-Aventis S.A.

Sun Pharmaceutical Industries Ltd.

Targin

Targin

Pfizer

Pfizer

Sun Pharmaceutical Industries Ltd.

Janssen Pharmaceuticals(Johnson & Johnson)

Oxycodone Drug Segment by Type

Anesthesia

Anesthesia

Others

Pain Management

Pain Management

Others

Oxycodone Drug Segment by Application

Ambulatory Surgical Centers (ASCs)

Ambulatory Surgical Centers (ASCs)

Hospitals & Clinics

Hospitals & Clinics

Oxycodone Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Oxycodone Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Oxycodone Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oxycodone Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oxycodone Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Anesthesia Major Manufacturers Table 3. Anesthesia Major Manufacturers Table 4. Others Major Manufacturers Table 5. Pain Management Major Manufacturers Table 6. Pain Management Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Oxycodone Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Ambulatory Surgical Centers (ASCs) Major Manufacturers Table 10. Ambulatory Surgical Centers (ASCs) Major Manufacturers Table 11. Hospitals & Clinics Major Manufacturers Table 12. Hospitals & Clinics Major Manufacturers Table 13. Oxycodone Drug Industry Trends Table 14. Oxycodone Drug Industry Drivers Table 15. Oxycodone Drug Industry Opportunities and Challenges Table 16. Oxycodone Drug Industry Restraints Table 17. Global Oxycodone Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Oxycodone Drug Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Oxycodone Drug Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Oxycodone Drug Revenue Market Share by Region (2021-2026) Table 21. Global Oxycodone Drug Revenue Market Share by Region (2027-2032) Table 22. Global Oxycodone Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Oxycodone Drug Sales by Region (2021-2026) & (K Units) Table 24. Global Oxycodone Drug Sales by Region (2027-2032) & (K Units) Table 25. Global Oxycodone Drug Sales Market Share by Region (2021-2026) Table 26. Global Oxycodone Drug Sales Market Share by Region (2027-2032) Table 27. Global Oxycodone Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Oxycodone Drug Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Oxycodone Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Oxycodone Drug Sales Market Share by Manufacturers (2021-2026) Table 31. Global Oxycodone Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Oxycodone Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Oxycodone Drug Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Oxycodone Drug Manufacturers, Product Type & Application Table 35. Global Oxycodone Drug Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Oxycodone Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Oxycodone Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Oxycodone Drug Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Oxycodone Drug Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Oxycodone Drug Revenue Market Share by Type (2021-2026) Table 42. Global Oxycodone Drug Revenue Market Share by Type (2027-2032) Table 43. Global Oxycodone Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Oxycodone Drug Sales by Type (2021-2026) & (K Units) Table 45. Global Oxycodone Drug Sales by Type (2027-2032) & (K Units) Table 46. Global Oxycodone Drug Sales Market Share by Type (2021-2026) Table 47. Global Oxycodone Drug Sales Market Share by Type (2027-2032) Table 48. Global Oxycodone Drug Price by Type (2021-2026) & (US$/Unit) Table 49. Global Oxycodone Drug Price by Type (2027-2032) & (US$/Unit) Table 50. Global Oxycodone Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Oxycodone Drug Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Oxycodone Drug Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Oxycodone Drug Revenue Market Share by Application (2021-2026) Table 54. Global Oxycodone Drug Revenue Market Share by Application (2027-2032) Table 55. Global Oxycodone Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Oxycodone Drug Sales by Application (2021-2026) & (K Units) Table 57. Global Oxycodone Drug Sales by Application (2027-2032) & (K Units) Table 58. Global Oxycodone Drug Sales Market Share by Application (2021-2026) Table 59. Global Oxycodone Drug Sales Market Share by Application (2027-2032) Table 60. Global Oxycodone Drug Price by Application (2021-2026) & (US$/Unit) Table 61. Global Oxycodone Drug Price by Application (2027-2032) & (US$/Unit) Table 62. Endone Company Information Table 63. Endone Business Overview Table 64. Endone Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Endone Oxycodone Drug Product Portfolio Table 66. Endone Recent Development Table 67. Endone Company Information Table 68. Endone Business Overview Table 69. Endone Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Endone Oxycodone Drug Product Portfolio Table 71. Endone Recent Development Table 72. Hikma Pharmaceuticals USA Company Information Table 73. Hikma Pharmaceuticals USA Business Overview Table 74. Hikma Pharmaceuticals USA Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio Table 76. Hikma Pharmaceuticals USA Recent Development Table 77. Hikma Pharmaceuticals USA Company Information Table 78. Hikma Pharmaceuticals USA Business Overview Table 79. Hikma Pharmaceuticals USA Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio Table 81. Hikma Pharmaceuticals USA Recent Development Table 82. Janssen Pharmaceuticals(Johnson & Johnson) Company Information Table 83. Janssen Pharmaceuticals(Johnson & Johnson) Business Overview Table 84. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio Table 86. Janssen Pharmaceuticals(Johnson & Johnson) Recent Development Table 87. OxyContin Company Information Table 88. OxyContin Business Overview Table 89. OxyContin Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. OxyContin Oxycodone Drug Product Portfolio Table 91. OxyContin Recent Development Table 92. OxyContin Company Information Table 93. OxyContin Business Overview Table 94. OxyContin Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. OxyContin Oxycodone Drug Product Portfolio Table 96. OxyContin Recent Development Table 97. Oxynorm Company Information Table 98. Oxynorm Business Overview Table 99. Oxynorm Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Oxynorm Oxycodone Drug Product Portfolio Table 101. Oxynorm Recent Development Table 102. Oxynorm Company Information Table 103. Oxynorm Business Overview Table 104. Oxynorm Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Oxynorm Oxycodone Drug Product Portfolio Table 106. Oxynorm Recent Development Table 107. Proladone Company Information Table 108. Proladone Business Overview Table 109. Proladone Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Proladone Oxycodone Drug Product Portfolio Table 111. Proladone Recent Development Table 112. Proladone Company Information Table 113. Proladone Business Overview Table 114. Proladone Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Proladone Oxycodone Drug Product Portfolio Table 116. Proladone Recent Development Table 117. Purdue Pharma L.P Company Information Table 118. Purdue Pharma L.P Business Overview Table 119. Purdue Pharma L.P Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Purdue Pharma L.P Oxycodone Drug Product Portfolio Table 121. Purdue Pharma L.P Recent Development Table 122. Purdue Pharma L.P Company Information Table 123. Purdue Pharma L.P Business Overview Table 124. Purdue Pharma L.P Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Purdue Pharma L.P Oxycodone Drug Product Portfolio Table 126. Purdue Pharma L.P Recent Development Table 127. Sanofi-Aventis S.A. Company Information Table 128. Sanofi-Aventis S.A. Business Overview Table 129. Sanofi-Aventis S.A. Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio Table 131. Sanofi-Aventis S.A. Recent Development Table 132. Sanofi-Aventis S.A. Company Information Table 133. Sanofi-Aventis S.A. Business Overview Table 134. Sanofi-Aventis S.A. Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio Table 136. Sanofi-Aventis S.A. Recent Development Table 137. Sun Pharmaceutical Industries Ltd. Company Information Table 138. Sun Pharmaceutical Industries Ltd. Business Overview Table 139. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio Table 141. Sun Pharmaceutical Industries Ltd. Recent Development Table 142. Targin Company Information Table 143. Targin Business Overview Table 144. Targin Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Targin Oxycodone Drug Product Portfolio Table 146. Targin Recent Development Table 147. Targin Company Information Table 148. Targin Business Overview Table 149. Targin Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Targin Oxycodone Drug Product Portfolio Table 151. Targin Recent Development Table 152. Pfizer Company Information Table 153. Pfizer Business Overview Table 154. Pfizer Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Pfizer Oxycodone Drug Product Portfolio Table 156. Pfizer Recent Development Table 157. Pfizer Company Information Table 158. Pfizer Business Overview Table 159. Pfizer Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Pfizer Oxycodone Drug Product Portfolio Table 161. Pfizer Recent Development Table 162. Sun Pharmaceutical Industries Ltd. Company Information Table 163. Sun Pharmaceutical Industries Ltd. Business Overview Table 164. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio Table 166. Sun Pharmaceutical Industries Ltd. Recent Development Table 167. Janssen Pharmaceuticals(Johnson & Johnson) Company Information Table 168. Janssen Pharmaceuticals(Johnson & Johnson) Business Overview Table 169. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio Table 171. Janssen Pharmaceuticals(Johnson & Johnson) Recent Development Table 172. North America Oxycodone Drug Revenue by Type (2021-2026) & (US$ Million) Table 173. North America Oxycodone Drug Revenue by Type (2027-2032) & (US$ Million) Table 174. North America Oxycodone Drug Sales by Type (2021-2026) & (K Units) Table 175. North America Oxycodone Drug Sales by Type (2027-2032) & (K Units) Table 176. North America Oxycodone Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 177. North America Oxycodone Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 178. North America Oxycodone Drug Revenue by Application (2021-2026) & (US$ Million) Table 179. North America Oxycodone Drug Revenue by Application (2027-2032) & (US$ Million) Table 180. North America Oxycodone Drug Sales by Application (2021-2026) & (K Units) Table 181. North America Oxycodone Drug Sales by Application (2027-2032) & (K Units) Table 182. North America Oxycodone Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 183. North America Oxycodone Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 184. North America Oxycodone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. North America Oxycodone Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. North America Oxycodone Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. North America Oxycodone Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. North America Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 189. North America Oxycodone Drug Sales by Country (2027-2032) & (K Units) Table 190. North America Oxycodone Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 191. North America Oxycodone Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 192. United States Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 193. Canada Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 194. Europe Oxycodone Drug Revenue by Type (2021-2026) & (US$ Million) Table 195. Europe Oxycodone Drug Revenue by Type (2027-2032) & (US$ Million) Table 196. Europe Oxycodone Drug Sales by Type (2021-2026) & (K Units) Table 197. Europe Oxycodone Drug Sales by Type (2027-2032) & (K Units) Table 198. Europe Oxycodone Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 199. Europe Oxycodone Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 200. Europe Oxycodone Drug Revenue by Application (2021-2026) & (US$ Million) Table 201. Europe Oxycodone Drug Revenue by Application (2027-2032) & (US$ Million) Table 202. Europe Oxycodone Drug Sales by Application (2021-2026) & (K Units) Table 203. Europe Oxycodone Drug Sales by Application (2027-2032) & (K Units) Table 204. Europe Oxycodone Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 205. Europe Oxycodone Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 206. Europe Oxycodone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. Europe Oxycodone Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. Europe Oxycodone Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. Europe Oxycodone Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 210. Europe Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 211. Europe Oxycodone Drug Sales by Country (2027-2032) & (K Units) Table 212. Europe Oxycodone Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 213. Europe Oxycodone Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Germany Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 215. France Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 216. U.K. Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 217. Italy Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 218. Netherlands Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 219. China Oxycodone Drug Revenue by Type (2021-2026) & (US$ Million) Table 220. China Oxycodone Drug Revenue by Type (2027-2032) & (US$ Million) Table 221. China Oxycodone Drug Sales by Type (2021-2026) & (K Units) Table 222. China Oxycodone Drug Sales by Type (2027-2032) & (K Units) Table 223. China Oxycodone Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 224. China Oxycodone Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 225. China Oxycodone Drug Revenue by Application (2021-2026) & (US$ Million) Table 226. China Oxycodone Drug Revenue by Application (2027-2032) & (US$ Million) Table 227. China Oxycodone Drug Sales by Application (2021-2026) & (K Units) Table 228. China Oxycodone Drug Sales by Application (2027-2032) & (K Units) Table 229. China Oxycodone Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 230. China Oxycodone Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 231. Asia Oxycodone Drug Revenue by Type (2021-2026) & (US$ Million) Table 232. Asia Oxycodone Drug Revenue by Type (2027-2032) & (US$ Million) Table 233. Asia Oxycodone Drug Sales by Type (2021-2026) & (K Units) Table 234. Asia Oxycodone Drug Sales by Type (2027-2032) & (K Units) Table 235. Asia Oxycodone Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 236. Asia Oxycodone Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 237. Asia Oxycodone Drug Revenue by Application (2021-2026) & (US$ Million) Table 238. Asia Oxycodone Drug Revenue by Application (2027-2032) & (US$ Million) Table 239. Asia Oxycodone Drug Sales by Application (2021-2026) & (K Units) Table 240. Asia Oxycodone Drug Sales by Application (2027-2032) & (K Units) Table 241. Asia Oxycodone Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 242. Asia Oxycodone Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 243. Asia Oxycodone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 244. Asia Oxycodone Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 245. Asia Oxycodone Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 246. Asia Oxycodone Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 247. Asia Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 248. Asia Oxycodone Drug Sales by Country (2027-2032) & (K Units) Table 249. Asia Oxycodone Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 250. Asia Oxycodone Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 251. Japan Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 252. South Korea Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 253. India Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 254. Australia Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 255. China Taiwan Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 256. Southeast Asia Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 257. SAMEA Oxycodone Drug Revenue by Type (2021-2026) & (US$ Million) Table 258. SAMEA Oxycodone Drug Revenue by Type (2027-2032) & (US$ Million) Table 259. SAMEA Oxycodone Drug Sales by Type (2021-2026) & (K Units) Table 260. SAMEA Oxycodone Drug Sales by Type (2027-2032) & (K Units) Table 261. SAMEA Oxycodone Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 262. SAMEA Oxycodone Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 263. SAMEA Oxycodone Drug Revenue by Application (2021-2026) & (US$ Million) Table 264. SAMEA Oxycodone Drug Revenue by Application (2027-2032) & (US$ Million) Table 265. SAMEA Oxycodone Drug Sales by Application (2021-2026) & (K Units) Table 266. SAMEA Oxycodone Drug Sales by Application (2027-2032) & (K Units) Table 267. SAMEA Oxycodone Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 268. SAMEA Oxycodone Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 269. SAMEA Oxycodone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 270. SAMEA Oxycodone Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 271. SAMEA Oxycodone Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 272. SAMEA Oxycodone Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 273. SAMEA Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 274. SAMEA Oxycodone Drug Sales by Country (2027-2032) & (K Units) Table 275. SAMEA Oxycodone Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 276. SAMEA Oxycodone Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 277. Brazil Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 278. Argentina Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 279. Chile Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 280. Colombia Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 281. Peru Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 282. Saudi Arabia Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 283. Israel Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 284. UAE Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 285. Turkey Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 286. Iran Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 287. Egypt Oxycodone Drug Revenue (2021-2032) & (US$ Million) Table 288. Key Raw Materials Table 289. Raw Materials Key Suppliers Table 290. Oxycodone Drug Distributors List Table 291. Oxycodone Drug Customers List Table 292. Research Programs/Design for This Report Table 293. Authors List of This Report Table 294. Secondary Sources Table 295. Primary Sources List of Figures Figure 1. Oxycodone Drug Image Figure 2. Global Oxycodone Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oxycodone Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Anesthesia Image Figure 5. Anesthesia Image Figure 6. Others Image Figure 7. Pain Management Image Figure 8. Pain Management Image Figure 9. Others Image Figure 10. Global Oxycodone Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Oxycodone Drug Market Size Share 2021 VS 2025 VS 2032 Figure 12. Ambulatory Surgical Centers (ASCs) Image Figure 13. Ambulatory Surgical Centers (ASCs) Image Figure 14. Hospitals & Clinics Image Figure 15. Hospitals & Clinics Image Figure 16. Global Oxycodone Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Oxycodone Drug Revenue (2021-2032) & (US$ Million) Figure 18. Global Oxycodone Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Oxycodone Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Oxycodone Drug Revenue Market Share by Region (2021-2032) Figure 21. Global Oxycodone Drug Sales (2021-2032) & (K Units) Figure 22. Global Oxycodone Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Oxycodone Drug Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Oxycodone Drug Sales YoY (2021-2032) & (K Units) Figure 25. Europe Oxycodone Drug Sales YoY (2021-2032) & (K Units) Figure 26. China Oxycodone Drug Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Oxycodone Drug Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Oxycodone Drug Sales YoY (2021-2032) & (K Units) Figure 29. Global Oxycodone Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Oxycodone Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Oxycodone Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Oxycodone Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Oxycodone Drug Revenue Market Share by Type (2021-2032) Figure 35. Global Oxycodone Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Oxycodone Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Oxycodone Drug Sales Market Share by Type (2021-2032) Figure 38. Global Oxycodone Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Oxycodone Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Oxycodone Drug Revenue Market Share by Application (2021-2032) Figure 41. Global Oxycodone Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Oxycodone Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Oxycodone Drug Sales Market Share by Application (2021-2032) Figure 44. North America Oxycodone Drug Revenue Share by Type (2021-2032) Figure 45. North America Oxycodone Drug Sales Share by Type (2021-2032) Figure 46. North America Oxycodone Drug Revenue Share by Application (2021-2032) Figure 47. North America Oxycodone Drug Sales Share by Application (2021-2032) Figure 48. North America Oxycodone Drug Revenue Share by Country (2021-2032) Figure 49. North America Oxycodone Drug Sales Share by Country (2021-2032) Figure 50. Europe Oxycodone Drug Revenue Share by Type (2021-2032) Figure 51. Europe Oxycodone Drug Sales Share by Type (2021-2032) Figure 52. Europe Oxycodone Drug Revenue Share by Application (2021-2032) Figure 53. Europe Oxycodone Drug Sales Share by Application (2021-2032) Figure 54. Europe Oxycodone Drug Revenue Share by Country (2021-2032) Figure 55. Europe Oxycodone Drug Sales Share by Country (2021-2032) Figure 56. China Oxycodone Drug Revenue Share by Type (2021-2032) Figure 57. China Oxycodone Drug Sales Share by Type (2021-2032) Figure 58. China Oxycodone Drug Revenue Share by Application (2021-2032) Figure 59. China Oxycodone Drug Sales Share by Application (2021-2032) Figure 60. Asia Oxycodone Drug Revenue Share by Type (2021-2032) Figure 61. Asia Oxycodone Drug Sales Share by Type (2021-2032) Figure 62. Asia Oxycodone Drug Revenue Share by Application (2021-2032) Figure 63. Asia Oxycodone Drug Sales Share by Application (2021-2032) Figure 64. Asia Oxycodone Drug Revenue Share by Country (2021-2032) Figure 65. Asia Oxycodone Drug Sales Share by Country (2021-2032) Figure 66. SAMEA Oxycodone Drug Revenue Share by Type (2021-2032) Figure 67. SAMEA Oxycodone Drug Sales Share by Type (2021-2032) Figure 68. SAMEA Oxycodone Drug Revenue Share by Application (2021-2032) Figure 69. SAMEA Oxycodone Drug Sales Share by Application (2021-2032) Figure 70. SAMEA Oxycodone Drug Revenue Share by Country (2021-2032) Figure 71. SAMEA Oxycodone Drug Sales Share by Country (2021-2032) Figure 72. Oxycodone Drug Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Oxycodone Drug Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Anesthesia
  • Anesthesia
  • Others
  • Pain Management
  • Pain Management
  • Others
Applications
  • Ambulatory Surgical Centers (ASCs)
  • Ambulatory Surgical Centers (ASCs)
  • Hospitals & Clinics
  • Hospitals & Clinics
Companies covered
  • Endone
  • Endone
  • Hikma Pharmaceuticals USA
  • Hikma Pharmaceuticals USA
  • Janssen Pharmaceuticals(Johnson & Johnson)
  • OxyContin
  • OxyContin
  • Oxynorm
  • Oxynorm
  • Proladone
  • Proladone
  • Purdue Pharma L.P
  • Purdue Pharma L.P
  • Sanofi-Aventis S.A.
  • Sanofi-Aventis S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Targin
  • Targin
  • Pfizer
  • Pfizer
  • Sun Pharmaceutical Industries Ltd.
  • Janssen Pharmaceuticals(Johnson & Johnson)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oxycodone Drug Market by Type
  3. 1.2.1 Global Oxycodone Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Anesthesia
  5. 1.2.3 Anesthesia
  6. 1.2.4 Others
  7. 1.2.5 Pain Management
  8. 1.2.6 Pain Management
  9. 1.2.7 Others
  10. 1.3 Oxycodone Drug Market by Application
  11. 1.3.1 Global Oxycodone Drug Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Ambulatory Surgical Centers (ASCs)
  13. 1.3.3 Ambulatory Surgical Centers (ASCs)
  14. 1.3.4 Hospitals & Clinics
  15. 1.3.5 Hospitals & Clinics
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Oxycodone Drug Market Dynamics
  1. 2.1 Oxycodone Drug Industry Trends
  2. 2.2 Oxycodone Drug Industry Drivers
  3. 2.3 Oxycodone Drug Industry Opportunities and Challenges
  4. 2.4 Oxycodone Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Oxycodone Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Oxycodone Drug Revenue by Region
  3. 3.2.1 Global Oxycodone Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oxycodone Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Oxycodone Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Oxycodone Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Oxycodone Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Oxycodone Drug Sales by Region
  9. 3.4.1 Global Oxycodone Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Oxycodone Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Oxycodone Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Oxycodone Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Oxycodone Drug Revenue by Manufacturers
  2. 4.1.1 Global Oxycodone Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Oxycodone Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Oxycodone Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oxycodone Drug Sales by Manufacturers
  6. 4.2.1 Global Oxycodone Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Oxycodone Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Oxycodone Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Oxycodone Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Oxycodone Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Oxycodone Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Oxycodone Drug Manufacturers, Product Type & Application
  13. 4.7 Global Oxycodone Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Oxycodone Drug Market CR5 and HHI
  16. 4.8.2 2025 Oxycodone Drug Tier 1, Tier 2, and Tier 3
5 Oxycodone Drug Market by Type
  1. 5.1 Global Oxycodone Drug Revenue by Type
  2. 5.1.1 Global Oxycodone Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Oxycodone Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Oxycodone Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Oxycodone Drug Sales by Type
  6. 5.2.1 Global Oxycodone Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oxycodone Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Oxycodone Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Oxycodone Drug Price by Type
6 Oxycodone Drug Market by Application
  1. 6.1 Global Oxycodone Drug Revenue by Application
  2. 6.1.1 Global Oxycodone Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Oxycodone Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Oxycodone Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Oxycodone Drug Sales by Application
  6. 6.2.1 Global Oxycodone Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Oxycodone Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Oxycodone Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Oxycodone Drug Price by Application
7 Company Profiles
  1. 7.1 Endone
  2. 7.1.1 Endone Company Information
  3. 7.1.2 Endone Business Overview
  4. 7.1.3 Endone Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Endone Oxycodone Drug Product Portfolio
  6. 7.1.5 Endone Recent Developments
  7. 7.2 Endone
  8. 7.2.1 Endone Company Information
  9. 7.2.2 Endone Business Overview
  10. 7.2.3 Endone Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Endone Oxycodone Drug Product Portfolio
  12. 7.2.5 Endone Recent Developments
  13. 7.3 Hikma Pharmaceuticals USA
  14. 7.3.1 Hikma Pharmaceuticals USA Company Information
  15. 7.3.2 Hikma Pharmaceuticals USA Business Overview
  16. 7.3.3 Hikma Pharmaceuticals USA Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio
  18. 7.3.5 Hikma Pharmaceuticals USA Recent Developments
  19. 7.4 Hikma Pharmaceuticals USA
  20. 7.4.1 Hikma Pharmaceuticals USA Company Information
  21. 7.4.2 Hikma Pharmaceuticals USA Business Overview
  22. 7.4.3 Hikma Pharmaceuticals USA Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio
  24. 7.4.5 Hikma Pharmaceuticals USA Recent Developments
  25. 7.5 Janssen Pharmaceuticals(Johnson & Johnson)
  26. 7.5.1 Janssen Pharmaceuticals(Johnson & Johnson) Company Information
  27. 7.5.2 Janssen Pharmaceuticals(Johnson & Johnson) Business Overview
  28. 7.5.3 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio
  30. 7.5.5 Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments
  31. 7.6 OxyContin
  32. 7.6.1 OxyContin Company Information
  33. 7.6.2 OxyContin Business Overview
  34. 7.6.3 OxyContin Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 OxyContin Oxycodone Drug Product Portfolio
  36. 7.6.5 OxyContin Recent Developments
  37. 7.7 OxyContin
  38. 7.7.1 OxyContin Company Information
  39. 7.7.2 OxyContin Business Overview
  40. 7.7.3 OxyContin Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 OxyContin Oxycodone Drug Product Portfolio
  42. 7.7.5 OxyContin Recent Developments
  43. 7.8 Oxynorm
  44. 7.8.1 Oxynorm Company Information
  45. 7.8.2 Oxynorm Business Overview
  46. 7.8.3 Oxynorm Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Oxynorm Oxycodone Drug Product Portfolio
  48. 7.8.5 Oxynorm Recent Developments
  49. 7.9 Oxynorm
  50. 7.9.1 Oxynorm Company Information
  51. 7.9.2 Oxynorm Business Overview
  52. 7.9.3 Oxynorm Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Oxynorm Oxycodone Drug Product Portfolio
  54. 7.9.5 Oxynorm Recent Developments
  55. 7.10 Proladone
  56. 7.10.1 Proladone Company Information
  57. 7.10.2 Proladone Business Overview
  58. 7.10.3 Proladone Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Proladone Oxycodone Drug Product Portfolio
  60. 7.10.5 Proladone Recent Developments
  61. 7.11 Proladone
  62. 7.11.1 Proladone Company Information
  63. 7.11.2 Proladone Business Overview
  64. 7.11.3 Proladone Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Proladone Oxycodone Drug Product Portfolio
  66. 7.11.5 Proladone Recent Developments
  67. 7.12 Purdue Pharma L.P
  68. 7.12.1 Purdue Pharma L.P Company Information
  69. 7.12.2 Purdue Pharma L.P Business Overview
  70. 7.12.3 Purdue Pharma L.P Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Purdue Pharma L.P Oxycodone Drug Product Portfolio
  72. 7.12.5 Purdue Pharma L.P Recent Developments
  73. 7.13 Purdue Pharma L.P
  74. 7.13.1 Purdue Pharma L.P Company Information
  75. 7.13.2 Purdue Pharma L.P Business Overview
  76. 7.13.3 Purdue Pharma L.P Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Purdue Pharma L.P Oxycodone Drug Product Portfolio
  78. 7.13.5 Purdue Pharma L.P Recent Developments
  79. 7.14 Sanofi-Aventis S.A.
  80. 7.14.1 Sanofi-Aventis S.A. Company Information
  81. 7.14.2 Sanofi-Aventis S.A. Business Overview
  82. 7.14.3 Sanofi-Aventis S.A. Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio
  84. 7.14.5 Sanofi-Aventis S.A. Recent Developments
  85. 7.15 Sanofi-Aventis S.A.
  86. 7.15.1 Sanofi-Aventis S.A. Company Information
  87. 7.15.2 Sanofi-Aventis S.A. Business Overview
  88. 7.15.3 Sanofi-Aventis S.A. Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio
  90. 7.15.5 Sanofi-Aventis S.A. Recent Developments
  91. 7.16 Sun Pharmaceutical Industries Ltd.
  92. 7.16.1 Sun Pharmaceutical Industries Ltd. Company Information
  93. 7.16.2 Sun Pharmaceutical Industries Ltd. Business Overview
  94. 7.16.3 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio
  96. 7.16.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  97. 7.17 Targin
  98. 7.17.1 Targin Company Information
  99. 7.17.2 Targin Business Overview
  100. 7.17.3 Targin Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Targin Oxycodone Drug Product Portfolio
  102. 7.17.5 Targin Recent Developments
  103. 7.18 Targin
  104. 7.18.1 Targin Company Information
  105. 7.18.2 Targin Business Overview
  106. 7.18.3 Targin Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Targin Oxycodone Drug Product Portfolio
  108. 7.18.5 Targin Recent Developments
  109. 7.19 Pfizer
  110. 7.19.1 Pfizer Company Information
  111. 7.19.2 Pfizer Business Overview
  112. 7.19.3 Pfizer Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Pfizer Oxycodone Drug Product Portfolio
  114. 7.19.5 Pfizer Recent Developments
  115. 7.20 Pfizer
  116. 7.20.1 Pfizer Company Information
  117. 7.20.2 Pfizer Business Overview
  118. 7.20.3 Pfizer Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Pfizer Oxycodone Drug Product Portfolio
  120. 7.20.5 Pfizer Recent Developments
  121. 7.21 Sun Pharmaceutical Industries Ltd.
  122. 7.21.1 Sun Pharmaceutical Industries Ltd. Company Information
  123. 7.21.2 Sun Pharmaceutical Industries Ltd. Business Overview
  124. 7.21.3 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio
  126. 7.21.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  127. 7.22 Janssen Pharmaceuticals(Johnson & Johnson)
  128. 7.22.1 Janssen Pharmaceuticals(Johnson & Johnson) Company Information
  129. 7.22.2 Janssen Pharmaceuticals(Johnson & Johnson) Business Overview
  130. 7.22.3 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio
  132. 7.22.5 Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments
8 North America
  1. 8.1 North America Oxycodone Drug Market Size by Type
  2. 8.1.1 North America Oxycodone Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Oxycodone Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Oxycodone Drug Price by Type (2021-2032)
  5. 8.2 North America Oxycodone Drug Market Size by Application
  6. 8.2.1 North America Oxycodone Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Oxycodone Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Oxycodone Drug Price by Application (2021-2032)
  9. 8.3 North America Oxycodone Drug Market Size by Country
  10. 8.3.1 North America Oxycodone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Oxycodone Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Oxycodone Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Oxycodone Drug Market Size by Type
  2. 9.1.1 Europe Oxycodone Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Oxycodone Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Oxycodone Drug Price by Type (2021-2032)
  5. 9.2 Europe Oxycodone Drug Market Size by Application
  6. 9.2.1 Europe Oxycodone Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Oxycodone Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Oxycodone Drug Price by Application (2021-2032)
  9. 9.3 Europe Oxycodone Drug Market Size by Country
  10. 9.3.1 Europe Oxycodone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Oxycodone Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Oxycodone Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Oxycodone Drug Market Size by Type
  2. 10.1.1 China Oxycodone Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Oxycodone Drug Sales by Type (2021-2032)
  4. 10.1.3 China Oxycodone Drug Price by Type (2021-2032)
  5. 10.2 China Oxycodone Drug Market Size by Application
  6. 10.2.1 China Oxycodone Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Oxycodone Drug Sales by Application (2021-2032)
  8. 10.2.3 China Oxycodone Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oxycodone Drug Market Size by Type
  2. 11.1.1 Asia Oxycodone Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Oxycodone Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Oxycodone Drug Price by Type (2021-2032)
  5. 11.2 Asia Oxycodone Drug Market Size by Application
  6. 11.2.1 Asia Oxycodone Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Oxycodone Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Oxycodone Drug Price by Application (2021-2032)
  9. 11.3 Asia Oxycodone Drug Market Size by Country
  10. 11.3.1 Asia Oxycodone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Oxycodone Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Oxycodone Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oxycodone Drug Market Size by Type
  2. 12.1.1 SAMEA Oxycodone Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Oxycodone Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Oxycodone Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Oxycodone Drug Market Size by Application
  6. 12.2.1 SAMEA Oxycodone Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Oxycodone Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Oxycodone Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Oxycodone Drug Market Size by Country
  10. 12.3.1 SAMEA Oxycodone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Oxycodone Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Oxycodone Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Oxycodone Drug Value Chain Analysis
  2. 13.1.1 Oxycodone Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Oxycodone Drug Production Mode & Process
  6. 13.2 Oxycodone Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Oxycodone Drug Distributors
  9. 13.2.3 Oxycodone Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst